Lipella Pharmaceuticals Inc.
LIPO- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347242
No open-market purchases or sales by Lipella Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of LIPO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lipella Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Lipella Pharmaceuticals Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on Lipella Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 1, 20259:19 PM ET | Huang Leaf | 13G/A | 2.70%69.4K shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 9, 20258:43 PM ET | Kaufman Jonathan H | 13D/A | 4.90%212.3K shares | −3.10 ppfrom 8.00%Below 5% | Apr 7, 2025 | SEC |
| Apr 9, 20258:39 PM ET | Chancellor Michael B | 13D/A | 4.80%209.6K shares | −3.10 ppfrom 7.90%Below 5% | Apr 7, 2025 | SEC |
| Apr 7, 20257:20 PM ET | Kaufman Jonathan H | 13D/A | 8.00%212.3K shares | 0.00 ppfrom 8.00% | Apr 3, 2025 | SEC |
| Mar 19, 20256:23 PM ET | Kaufman Jonathan H | 13D/A | 8.00%212.3K shares | 0.00 ppfrom 8.00% | Mar 17, 2025 | SEC |
| Mar 17, 20258:18 PM ET | Kaufman Jonathan H | 13D/A | 8.00%212.3K shares | 0.00 ppfrom 8.00% | Mar 13, 2025 | SEC |
| Mar 11, 20258:09 PM ET | Kaufman Jonathan H | 13D/A | 8.00%212.3K shares | 0.00 ppfrom 8.00% | Mar 10, 2025 | SEC |
| Mar 3, 20255:01 PM ET | Kaufman Jonathan H | 13D/A | 8.00%212.3K shares | 0.00 ppfrom 8.00% | Feb 28, 2025 | SEC |
| Feb 10, 20255:35 PM ET | Chancellor Michael B | 13D/A | 7.90%209.6K shares | −2.10 ppfrom 10.00% | Feb 6, 2025 | SEC |
| Feb 10, 20255:32 PM ET | Kaufman Jonathan H | 13D/A | 8.00%212.3K shares | −2.10 ppfrom 10.10% | Feb 6, 2025 | SEC |
| Jan 30, 20255:28 PM ET | Chancellor Michael B | 13D/A | 10.00%209.6K shares | −1.50 ppfrom 11.50% | Jan 28, 2025 | SEC |
| Jan 30, 20255:27 PM ET | Kaufman Jonathan H | 13D/A | 10.10%212.3K shares | −1.60 ppfrom 11.70% | Jan 28, 2025 | SEC |
| Jan 23, 20256:11 PM ET | Chancellor Michael B | 13D/A | 11.50%209.6K shares | – | Jan 21, 2025 | SEC |
| Jan 23, 20256:08 PM ET | Kaufman Jonathan H | 13D/A | 11.70%212.3K shares | −4.50 ppfrom 16.20% | Jan 21, 2025 | SEC |
| Jan 17, 20258:17 PM ET | Kaufman Jonathan H | 13D/A | 16.20%212.3K shares | 0.00 ppfrom 16.20% | Jan 15, 2025 | SEC |
| Jan 3, 20259:25 PM ET | Kaufman Jonathan H | 13D/A | 16.20%212.3K shares | 0.00 ppfrom 16.20% | Dec 31, 2024 | SEC |
| Jan 3, 20253:54 PM ET | Sabby Management, LLCand 2 others | 13G/A | 4.90%60.3K shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 27, 20249:31 PM ET | Kaufman Jonathan H | 13D/A | 16.20%212.3K shares | – | Dec 23, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lipella Pharmaceuticals Inc. shares.
No Form 144 notices for Lipella Pharmaceuticals Inc. are on file.